| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |